These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 10208501)

  • 1. LDL-apheresis improves microalbuminuria in patients with severe familial heterozygous hypercholesterolemia.
    Sinzinger H; Kritz H
    Atherosclerosis; 1999 Mar; 143(1):223-4. PubMed ID: 10208501
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term follow-up of carotid atherosclerosis in patients with heterozygous familial hypercholesterolemia under LDL apheresis treatment.
    Donner MG; Richter WO; Schwandt P
    J Clin Apher; 1997; 12(4):202-3. PubMed ID: 9483185
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of low-density lipoprotein apheresis on kinetics of apolipoprotein B in heterozygous familial hypercholesterolemia.
    Maugeais C; Ouguerram K; Frénais R; Maugère P; Charbonnel B; Magot T; Krempf M
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1679-86. PubMed ID: 11297603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changes in serum lipids and lipoproteins in 3 cases of heterozygous familial hypercholesterolemia treated by LDL apheresis on dextran sulfate-cellulose columns].
    Delplanque B; Emmerich J; Norol F; Jourdan D; Duedari N; Jacotot B
    Ann Med Interne (Paris); 1988; 139 Suppl 1():80-2. PubMed ID: 2470282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects on coronary atherosclerosis of long-term treatment of familial hypercholesterolemia by LDL-apheresis.
    Mabuchi H; Koizumi J; Michishita I; Takeda M; Kajinami K; Fujita H; Inazu A; Uno Y; Shimizu M; Takeda R
    Beitr Infusionsther; 1988; 23():87-96. PubMed ID: 2484787
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of severe hypercholesterolemia by LDL-apheresis: cholesterol-lowering effect and clinical evaluation.
    Saito Y; Shinomiya M; Shirai K; Yoshida S
    Beitr Infusionsther; 1988; 23():160-71. PubMed ID: 2484772
    [No Abstract]   [Full Text] [Related]  

  • 7. Coronary atherosclerosis reduced in patients with familial hypercholesterolemia after intensive cholesterol lowering with low-density lipoprotein-apheresis: 1-year follow-up study. The Osaka LDL-Apheresis Multicenter Trial Group.
    Kitabatake A; Sato H; Hori M; Kamada T; Kubori S; Hoki N; Minamino T; Yamada M; Kato T
    Clin Ther; 1994; 16(3):416-28. PubMed ID: 7923308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short- and long-term effects of LDL-apheresis on lipoprotein (a) serum levels.
    Ritter MM; Sühler K; Richter W; Schwandt P
    Clin Chim Acta; 1990 Dec; 195(1-2):9-15. PubMed ID: 2151209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-density lipoprotein levels and not mutation status predict intima-media thickness in familial hypercholesterolemia.
    Fahed AC; Habib RH; Nemer GM; Azar ST; Andary RR; Arabi MT; Moubarak EM; Bitar FF; Haddad FF
    Ann Vasc Surg; 2014 Feb; 28(2):421-6. PubMed ID: 24120234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Biological efficacy of LDL apheresis in major hypercholesterolemia].
    Dairou F; Assogba U; Bruckert E; De Gennes JL; Turpin G
    Ann Med Interne (Paris); 1994; 145(5):328-32. PubMed ID: 7985942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Apheresis of low-density lipids in the treatment of hereditary hypercholesterolemia].
    Konovalov GA; Kukharchuk VV; Sinitsin VV; Trakht IN; Adamova IIu
    Vutr Boles; 1989; 28(4):133-6. PubMed ID: 2596087
    [No Abstract]   [Full Text] [Related]  

  • 12. From plasma-exchange to LDL-apheresis: new developments in the treatment of familial hypercholesterolemia.
    Postiglione A; Gnasso A; Mastranzo P; Montefusco S; Motti C; Gallotta G; Cortese C; Scarpato N
    Beitr Infusionsther; 1988; 23():74-80. PubMed ID: 2484784
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of intensive lipid lowering by low-density lipoprotein apheresis on regression of coronary atherosclerosis in patients with familial hypercholesterolemia: Japan Low-density Lipoprotein Apheresis Coronary Atherosclerosis Prospective Study (L-CAPS).
    Nishimura S; Sekiguchi M; Kano T; Ishiwata S; Nagasaki F; Nishide T; Okimoto T; Kutsumi Y; Kuwabara Y; Takatsu F; Nishikawa H; Daida H; Yamaguchi H
    Atherosclerosis; 1999 Jun; 144(2):409-17. PubMed ID: 10407502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunosorptive apheresis of LDL.
    Borberg H; Gaczkowski A; Oette K; Stoffel W
    Prog Clin Biol Res; 1990; 337():163-7. PubMed ID: 2191310
    [No Abstract]   [Full Text] [Related]  

  • 15. [LDL apheresis--an effective treatment of homozygous familial hypercholesterolemia].
    Kauppinen-Mäkelin R; Koivisto V; Virtanen KS; Taskinen MR; Miettinen T
    Duodecim; 1990; 106(21):1465-70. PubMed ID: 1364677
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term efficacy of low-density lipoprotein apheresis on coronary heart disease in familial hypercholesterolemia. Hokuriku-FH-LDL-Apheresis Study Group.
    Mabuchi H; Koizumi J; Shimizu M; Kajinami K; Miyamoto S; Ueda K; Takegoshi T
    Am J Cardiol; 1998 Dec; 82(12):1489-95. PubMed ID: 9874053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of LDL apheresis in a case of homozygous familial hypercholesterolemia.
    Naveen T; Biswas A; Wig N; Soneja M; Jorwal P; Durga CS; Singla P; Chaudhary C; Baitha U
    Drug Discov Ther; 2019; 13(1):59-61. PubMed ID: 30880324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Low-density lipoprotein apheresis in familial hypercholesterolemia resistant to intensive medical treatment].
    Arbona C; Martinez-Hervás S; Goterris R; Montoro J; Real JT; Ascaso JF
    Med Clin (Barc); 2013 Mar; 140(5):207-10. PubMed ID: 22571847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LDL-apheresis with the HELP system: a 16-month study in severe hypercholesterolemic patients with ischemic heart disease.
    Baggio G; Previato L; Corti C; Bilato C; Belloni M; Ongaro G; Crepaldi G
    Beitr Infusionsther; 1988; 23():146-51. PubMed ID: 2484770
    [No Abstract]   [Full Text] [Related]  

  • 20. LDL-apheresis decreases plasma levels and urinary excretion of 8-epi-PGF2alpha.
    Oguogho A; Ferlitsch A; Sinzinger H
    Prostaglandins Leukot Essent Fatty Acids; 2000 Apr; 62(4):209-16. PubMed ID: 10882184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.